ARTICLE | Clinical News
Single-agent ribavirin regulatory update
August 18, 2014 7:00 AM UTC
Pharmascience’s Pendopharm division said Health Canada approved single-agent Ibavyr ribavirin to treat HCV infection. Pendopharm said that ribavirin is available only in kits with interferon in Canada...